Our Commitment to provide meaningful local cancer
Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. This disruptive approach may reshape future treatment opportunities.
Cancer is one of the leading causes of death worldwide and accounted for 7.6 million deaths (around 13% of all deaths) in 2008. In the Western World and in the U.S. cancer represents the second-leading cause of death after heart attack.
The NanoXray technology comprises three products having the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may overcome the current limitations of standard of care in local therapy. Local treatment (surgery and radiotherapy) plays a seminal role in the potential cure and gives systemic treatment a better chance to increase life expectancy. NanoXray products are developed to selectively increase the efficacy of radiotherapy in the tumor cell.